Want to see IKT full AI Analyst Report?
ETFs with Inhibikase Therapeutics (IKT) Exposure
The following ETFs maintain exposure to Inhibikase Therapeutics (IKT). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
19 ETFs Hold Inhibikase Therapeutics (IKT)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in IKT |
|---|---|---|---|---|---|---|
| SBIO | ALPS Medical Breakthroughs ETF | $187.80M | 0.50% | 0.14% | $262.77K | 0.12% |
| IWC | iShares Micro-Cap ETF | $1.26B | 0.60% | 0.06% | $730.17K | 0.31% |
| VTWV | Vanguard Russell 2000 Value ETF | $1.31B | 0.06% | 0.02% | $274.15K | 0.10% |
| IWN | iShares Russell 2000 Value ETF | $14.23B | 0.24% | 0.02% | $2.16M | 0.93% |
| VTWO | Vanguard Russell 2000 ETF | $17.04B | 0.06% | <0.01% | $1.73M | 0.60% |
| VRSD | Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD | $2.24M | ― | <0.01% | $1,302.87 | <0.01% |
| RTYS | Invesco Russell 2000 UCITS ETF | $318.41M | 0.25% | <0.01% | $25.63K | 0.01% |
| RSSL | Global X Russell 2000 ETF | $1.47B | 0.08% | <0.01% | $116.64K | 0.05% |
| ITWO | ProShares Russell 2000 High Income ETF | $182.44M | 0.55% | <0.01% | $13.61K | <0.01% |
| IWM | iShares Russell 2000 ETF | $76.76B | 0.19% | <0.01% | $5.67M | 2.43% |
| RB | ProShares Russell 2000 Dynamic Buffer ETF | $1.17M | 0.58% | <0.01% | $83.5 | <0.01% |
| AVSC | Avantis U.S Small Cap Equity ETF | $3.23B | 0.25% | <0.01% | $228.29K | 0.10% |
| R2EH | State Street SPDR RUSSELL 2000 U.S. SMALL CAP UCITS ETF Accum Shs - Hedged EUR | $148.28M | 0.46% | <0.01% | $207.00K | 0.09% |
| VXF | Vanguard Extended Market ETF | $30.86B | 0.05% | <0.01% | $2.41M | 0.84% |
| HDG | ProShares Hedge Replication ETF | $22.40M | 0.95% | <0.01% | $293.92 | <0.01% |
| DDGC | Dimensional Funds ICAV - Global Core Equity UCITS ETF Accum USD | ― | 0.31% | <0.01% | $7,682 | <0.01% |
| VTHR | Vanguard Russell 3000 ETF | $4.90B | 0.06% | <0.01% | $22.03K | <0.01% |
| VTI | Vanguard Total Stock Market ETF | $701.51B | 0.03% | <0.01% | $7.74M | 2.70% |
| DFSU | Dimensional US Sustainability Core 1 ETF | $2.41B | 0.15% | <0.01% | $7,214.4 | <0.01% |
| Symbol | % Weight in ETF | ETF Name | AUM | Expense Ratio | Market Value | % Weight in IKT |
|---|---|---|---|---|---|---|
| SBIO | 0.14% | ALPS Medical Breakthroughs ETF | $187.80M | 0.50% | $262.77K | 0.12% |
| IWC | 0.06% | iShares Micro-Cap ETF | $1.26B | 0.60% | $730.17K | 0.31% |
| VTWV | 0.02% | Vanguard Russell 2000 Value ETF | $1.31B | 0.06% | $274.15K | 0.10% |
| IWN | 0.02% | iShares Russell 2000 Value ETF | $14.23B | 0.24% | $2.16M | 0.93% |
| VTWO | <0.01% | Vanguard Russell 2000 ETF | $17.04B | 0.06% | $1.73M | 0.60% |
| VRSD | <0.01% | Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD | $2.24M | ― | $1,302.87 | <0.01% |
| RTYS | <0.01% | Invesco Russell 2000 UCITS ETF | $318.41M | 0.25% | $25.63K | 0.01% |
| RSSL | <0.01% | Global X Russell 2000 ETF | $1.47B | 0.08% | $116.64K | 0.05% |
| ITWO | <0.01% | ProShares Russell 2000 High Income ETF | $182.44M | 0.55% | $13.61K | <0.01% |
| IWM | <0.01% | iShares Russell 2000 ETF | $76.76B | 0.19% | $5.67M | 2.43% |
| RB | <0.01% | ProShares Russell 2000 Dynamic Buffer ETF | $1.17M | 0.58% | $83.5 | <0.01% |
| AVSC | <0.01% | Avantis U.S Small Cap Equity ETF | $3.23B | 0.25% | $228.29K | 0.10% |
| R2EH | <0.01% | State Street SPDR RUSSELL 2000 U.S. SMALL CAP UCITS ETF Accum Shs - Hedged EUR | $148.28M | 0.46% | $207.00K | 0.09% |
| VXF | <0.01% | Vanguard Extended Market ETF | $30.86B | 0.05% | $2.41M | 0.84% |
| HDG | <0.01% | ProShares Hedge Replication ETF | $22.40M | 0.95% | $293.92 | <0.01% |
| DDGC | <0.01% | Dimensional Funds ICAV - Global Core Equity UCITS ETF Accum USD | ― | 0.31% | $7,682 | <0.01% |
| VTHR | <0.01% | Vanguard Russell 3000 ETF | $4.90B | 0.06% | $22.03K | <0.01% |
| VTI | <0.01% | Vanguard Total Stock Market ETF | $701.51B | 0.03% | $7.74M | 2.70% |
| DFSU | <0.01% | Dimensional US Sustainability Core 1 ETF | $2.41B | 0.15% | $7,214.4 | <0.01% |
Popular ETF Comparisons
IKT ETF Exposure FAQ
What ETFs hold Inhibikase Therapeutics stock?
Inhibikase Therapeutics (IKT) is currently held by 19 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to IKT include iShares (IWM), iShares (IWN) and Vanguard (VTWO).
Which ETF has the largest exposure to IKT?
The ETF with the largest exposure to IKT is iShares (IWM), with approximately $5.67M in market value exposure.
How much IKT stock is held by ETFs?
ETFs currently hold approximately $10.98M worth of Inhibikase Therapeutics (IKT) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.